メディカルテクニカ有限会社の在庫品を大特価でご提案申し上げます

2013年1月31日木曜日

Masimo’s Oximeters and Neonatal Sensors for Critical Congenital Heart Disease (CCHD) Screening

Masimo has announced that the firm’s Signal Extraction Technology (SET) pulse oximeters, rainbow SET Pulse CO-Oximeters, and neonatal sensors have been cleared by the FDA for use in screening newborns for critical congenital heart disease (CCHD).

0 件のコメント:

コメントを投稿